|
End-of-day quote
Shenzhen S.E.
20/08/2026
|
5-day change | 1st Jan Change | ||
| 6.440 CNY | +10.09% |
|
+6.98% | -12.62% |
| 02/06 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 07/05 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 6.62B 984M 842M 786M 721M 1.35B 94.12B 1.38B 9.32B 3.63B 47.17B 3.69B 3.61B 156B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 5.47B 814M 697M 650M 597M 1.12B 77.88B 1.14B 7.71B 3.01B 39.03B 3.06B 2.99B 129B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.66% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | +10.09% | ||
| 1 week | +6.98% | ||
| Current month | +14.59% | ||
| 1 month | +9.15% | ||
| 3 months | +2.55% | ||
| 6 months | +1.26% | ||
| Current year | -12.62% |
| 1 week | 5.82 |  | 6.44 |
| 1 month | 5.2 | | 6.44 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 11/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 24/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 11/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 11/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 24/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 11/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/11/25 | Buy | Director | 100 | 0.0000% | ||
| 29/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 28/10/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.09% | +6.98% | -21.65% | -30.15% | 893M | |
| -1.16% | +4.55% | +79.18% | +129.80% | 1,141B | |
| -1.08% | +3.52% | +51.71% | +62.12% | 659B | |
| -0.45% | +5.79% | +26.86% | +76.70% | 470B | |
| +1.20% | +2.62% | +41.69% | +46.21% | 366B | |
| -0.61% | +2.10% | +23.43% | +40.38% | 302B | |
| +0.32% | +3.25% | +0.94% | +13.25% | 254B | |
| -1.76% | +4.32% | +47.03% | +67.20% | 239B | |
| -1.10% | -0.70% | -14.31% | -53.04% | 207B | |
| -1.51% | +5.65% | +22.93% | +92.19% | 183B | |
| Average | +0.36% | +4.36% | +25.78% | +44.46% | 382.19B | |
| Weighted average by Cap. | -0.77% | +4.31% | +45.03% | +73.14% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 98.19M 84.07M 78.44M 71.97M 135M 9.4B 138M 931M 363M 4.71B 369M 361M 15.59B | 624M 92.72M 79.39M 74.07M 67.97M 128M 8.87B 130M 879M 343M 4.45B 348M 341M 14.72B |
| Net income | -74.07M -11.01M -9.43M -8.8M -8.07M -15.17M -1.05B -15.47M -104M -40.68M -528M -41.35M -40.45M -1.75B | -347M -51.62M -44.2M -41.24M -37.84M -71.1M -4.94B -72.5M -489M -191M -2.48B -194M -190M -8.2B |
| Net Debt | -1.98B -295M -252M -235M -216M -406M -28.2B -414M -2.79B -1.09B -14.13B -1.11B -1.08B -46.79B | -1.14B -170M -145M -136M -124M -234M -16.24B -238M -1.61B -627M -8.14B -637M -623M -26.94B |
Employees
901
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | CNY 6.440 | +10.09% | 17,006,790 |
| 19/08/26 | CNY 5.850 | -3.47% | 25,701,164 |
| 18/08/26 | CNY 6.060 | -1.78% | 29,334,716 |
| 17/08/26 | CNY 6.170 | +2.15% | 34,432,375 |
| 14/08/26 | CNY 6.040 | -0.98% | 32,968,396 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
